Encompass Health (NYSE:EHC) Rating Lowered to “Hold” at Wall Street Zen

Encompass Health (NYSE:EHC) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday.

Other research analysts have also issued reports about the stock. Zacks Research lowered shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. KeyCorp upped their price objective on Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a research note on Tuesday, September 16th. Raymond James Financial raised Encompass Health to a “strong-buy” rating in a research report on Friday, October 31st. Finally, Barclays boosted their target price on Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a report on Thursday, October 30th. Two investment analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $142.86.

Encompass Health Trading Down 2.0%

EHC opened at $102.89 on Friday. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.76. Encompass Health has a 52 week low of $90.67 and a 52 week high of $127.99. The business’s 50 day moving average is $110.79 and its two-hundred day moving average is $116.97. The firm has a market cap of $10.35 billion, a price-to-earnings ratio of 19.45, a price-to-earnings-growth ratio of 1.66 and a beta of 0.74.

Encompass Health (NYSE:EHC) last announced its earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share (EPS) for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 17.84%. The business had revenue of $136.30 million for the quarter. On average, research analysts predict that Encompass Health will post 4.8 EPS for the current year.

Institutional Trading of Encompass Health

A number of institutional investors have recently modified their holdings of the business. Citizens National Bank Trust Department purchased a new position in Encompass Health in the third quarter worth $26,000. First Horizon Corp purchased a new stake in shares of Encompass Health during the 3rd quarter worth $34,000. Westside Investment Management Inc. grew its stake in shares of Encompass Health by 56.7% during the 3rd quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock worth $35,000 after purchasing an additional 101 shares during the period. Assetmark Inc. increased its holdings in shares of Encompass Health by 88.1% in the 3rd quarter. Assetmark Inc. now owns 299 shares of the company’s stock valued at $38,000 after purchasing an additional 140 shares in the last quarter. Finally, Root Financial Partners LLC acquired a new stake in shares of Encompass Health in the third quarter valued at about $39,000. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.